| 2019 | The Ratio of Peripheral Regulatory T Cells to Lox-1+ Polymorphonuclear Myeloid-derived Suppressor Cells Predicts the Early Response to Anti-PD-1 Therapy in Patients with Non-Small Cell Lung Cancer | 김혜련, 윤홍인, 정인경, 조병철 | article |
| 2018 | Survival and Functional Outcome after Treatment for Primary Base of Tongue Cancer: A Comparison of Definitive Chemoradiotherapy versus Surgery Followed by Adjuvant Radiotherapy.
| 고윤우, 금기창, 김세헌, 김혜련, 이정심, 이창걸, 조연아, 최은창 | article |
| 2018 | The Benefit of Pro Re Nata Antiemetics Provided With Guideline-Consistent Antiemetics in Delayed Nausea Control | 김건민, 김혜련, 라선영, 손주혁 | article |
| 2018 | Efficacy and safety of vinorelbine plus cisplatin chemotherapy for patients with recurrent and/or metastatic salivary gland cancer of the head and neck | 고윤우, 김진아, 김혜련, 윤선옥, 조병철, 최은창, 홍민희 | article |
| 2018 | ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma | 강한나, 김혜련, 윤미란, 조병철, 홍민희 | article |
| 2018 | Effects of Serum Albumin, Calcium Levels, Cancer Stage and Performance Status on Weight Loss in Parathyroid Hormone-Related Peptide Positive or Negative Patients with Cancer
| 강은석, 김혜련, 이병완, 이용호, 이지연, 차봉수, 홍남기 | article |
| 2018 | Radon Exposure-induced Genetic Variations in Lung Cancers among Never Smokers
| 김혜련 | article |
| 2018 | Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors. | 김혜련, 심효섭, 조병철, 표경호, 홍민희 | article |
| 2018 | Characteristics and Outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical Practice. | 김혜련, 안병철, 조병철, 홍민희 | article |
| 2018 | Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation | 김대준, 김진아, 김혜련, 박성용, 백순명, 심효섭, 윤미란, 이진구, 이한나, 조병철, 표경호, 홍민희 | article |
| 2018 | A Clinical Trial of Combination Neoadjuvant Chemotherapy and Transoral Robotic Surgery in Patients with T3 and T4 Laryngo-Hypopharyngeal Cancer | 금기창, 김다희, 김세헌, 김혜련, 조남훈, 조병철 | article |
| 2017 | Establishment of a Conditional Transgenic Mouse Model Recapitulating EML4-ALK-Positive Human Non-Small Cell Lung Cancer | 강한나, 김상균, 김성무, 김혜련, 김환, 윤미란, 임선민, 조병철, 표경호 | article |
| 2017 | Predictive factors of early distant brain failure after gamma knife radiosurgery alone in patients with brain metastases of non-small-cell lung cancer | 김혜련, 박용구, 장원석, 장진우, 정현호, 조병철 | article |
| 2017 | Significance of immune checkpoint proteins in EGFR-mutant non-small cell lung cancer | 김혜련, 조병철 | article |
| 2017 | Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01) | 김혜련, 조재용 | article |
| 2017 | Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer
| 김혜련 | article |
| 2017 | Next-generation sequencing reveals novel resistance mechanisms and molecular heterogeneity in EGFR-mutant non-small cell lung cancer with acquired resistance to EGFR-TKIs | 김상우, 김성무, 김혜련, 양인석, 이충근, 조병철 | article |
| 2017 | Concordance of programmed death-ligand 1 expression between primary and metastatic non-small cell lung cancer by immunohistochemistry and RNA in situ hybridization
| 김혜련, 심효섭, 이진구, 이창영, 정인경, 조병철, 차윤진, 홍민희 | article |
| 2017 | Prevalence and prognostic implications of psychological distress in patients with gastric cancer
| 김건민, 김경란, 김혜련, 노성훈, 라선영, 송수경, 정현철 | article |
| 2017 | Detection of activating and acquired resistant mutation in plasma from EGFR-mutated NSCLC patients by peptide nucleic acid (PNA) clamping-assisted fluorescence melting curve analysis
| 김지형, 김혜련, 박형순, 심효섭, 이진구, 이창영, 조병철, 차윤진, 허수진, 홍민희 | article |
| 2017 | Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement. | 김주항, 김혜련, 심효섭, 임선민, 조병철 | article |
| 2017 | Optimal dose and volume for postoperative radiotherapy in brain oligometastases from lung cancer: a retrospective study
| 김혜련, 서창옥, 이창걸, 장종희, 조병철 | article |
| 2017 | Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma | 김은영, 김진아, 김혜련, 백순명, 심효섭, 이진구, 조병철, 홍민희 | article |
| 2017 | Validation of ALK/ROS1 Dual Break Apart FISH Probe probe in non-small-cell lung cancer | 김혜련, 심효섭, 조병철, 차윤진 | article |
| 2017 | A randomized; phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01) (vol 8; pg 15943; 2017)
| 김주항, 김혜련, 정인경, 조병철 | article |
| 2017 | Architectural patterns of p16 immunohistochemical expression associated with cancer immunity and prognosis of head and neck squamous cell carcinoma | 김은경, 김혜련, 윤선옥, 조병철, 허수진 | article |
| 2017 | Transoral robotic surgery-based therapy in patients with stage III-IV oropharyngeal squamous cell carcinoma | 금기창, 김세헌, 김혜련, 박영민, 조남훈, 조병철 | article |
| 2017 | Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study | 김혜련, 조병철 | article |
| 2016 | Exome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck
| 고윤우, 김상우, 김한상, 김혜련, 조병철, 최은창 | article |
| 2016 | Clinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 status. | 김혜련, 심효섭, 이창영, 조병철, 차윤진 | article |
| 2016 | Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants
| 김혜련, 심효섭, 차윤진 | article |
| 2016 | Induction docetaxel and S-1 followed by concomitant radiotherapy with low-dose daily cisplatin in locally advanced head and neck carcinoma | 고윤우, 김주항, 김혜련, 이창걸, 조병철, 최은창 | article |
| 2016 | Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02)
| 김혜련 | article |
| 2016 | Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus
| 김상우, 김소라, 김현기, 김혜련, 김효송, 박형순, 양인석, 이민구, 임선민, 정현철, 조병철 | article |
| 2016 | EGFR-Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E-Mutant NSCLC Cell Lines
| 김민환, 김주항, 김혜련, 문용화, 백순명, 임선민, 조병철 | article |
| 2016 | Serum PTHrP Predicts Weight Loss in Cancer Patients Independent of Hypercalcemia, Inflammation, and Tumor Burden | 강은석, 김혜련, 이병완, 이용호, 이유미, 이현철, 차봉수, 홍남기 | article |
| 2016 | PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
| 김대준, 김현기, 김혜련, 김효송, 박준철, 배윤성, 신성관, 이상길, 이용찬, 이창걸, 정현수, 조병철, 허진 | article |
| 2016 | Alteration status and prognostic value of MET in head and neck squamous cell carcinoma
| 김혜련, 윤선옥, 조병철, 조윤아, 허수진 | article |
| 2016 | PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients
| 고윤우, 김은경, 김혜련, 윤선옥, 정인경, 조병철, 최은창, 표경호, 허수진, 홍민희 | article |
| 2016 | A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer | 김혜련, 심효섭, 임선민, 정인경, 조병철, 허수진 | article |
| 2016 | Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy | 김주항, 김혜련, 박형순, 이민구, 조병철, 조응혁 | article |
| 2016 | Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases From Lung Adenocarcinoma: Early Response and Dosimetric Evaluation. | 김준원, 김혜련, 서양권, 이창걸, 조병철, 조재호, 최치환 | article |
| 2016 | Assessment of Adrenal Function and Health-Related Quality of Life in Advanced Gastric Cancer Patients Who Received First-Line Chemotherapy. | 김지형, 김혜련, 노성훈, 라선영, 송수경, 송승은, 이유미, 이호선 | article |
| 2016 | Targeted sequencing identifies genetic alterations that confer primary resistance to EGFR tyrosine kinase inhibitor (Korean Lung Cancer Consortium)
| 김혜련, 임선민, 조병철 | article |
| 2016 | Pilot Study of a Next-Generation Sequencing-Based Targeted Anticancer Therapy in Refractory Solid Tumors at a Korean Institution
| 김상우, 김혜련, 박형순, 이민구 | article |
| 2016 | Clinical course of stage IV invasive mucinous adenocarcinoma of the lung | 김혜련, 심효섭, 이혜정, 조병철 | article |
| 2016 | ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models | 김혜련, 박혜지, 임선민, 조병철, 표경호, 한주연 | article |
| 2016 | Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative
| 김은영, 김혜련, 백순명, 심효섭, 임선민, 임승택, 조병철 | article |
| 2016 | Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy
| 김혜련, 백순명, 조병철, 표경호 | article |
| 2016 | Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase 2 study | 김혜련, 조병철 | article |
http://orcid.org/0000-0002-1842-9070
(Yonsei Health Research Network)
(8583782700)
